Addition of Capecitabine to Adjuvant Chemotherapy May be the Most Effective Strategy for Patients With Early-Stage Triple-Negative Breast Cancer: A Network Meta-Analysis of 9 Randomized Controlled Trials

BACKGROUND AND OBJECTIVE: Previous studies determined the therapeutic effects of capecitabine-based chemotherapy regimens on early-stage triple-negative breast cancer (TNBC). However, the optimal strategy of capecitabine-based chemotherapy remains uncertain. We conducted this network meta-analysis t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhiyang, Zheng, Jiehua, Ji, Zeqi, Chen, Lingzhi, Wu, Jinyao, Zou, Juan, Liu, Yiyuan, Lin, Weixun, Cai, Jiehui, Chen, Yaokun, Chen, Yexi, Lu, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358934/
https://www.ncbi.nlm.nih.gov/pubmed/35957836
http://dx.doi.org/10.3389/fendo.2022.939048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358934/
https://www.ncbi.nlm.nih.gov/pubmed/35957836
http://dx.doi.org/10.3389/fendo.2022.939048

Ejemplares similares